140 related articles for article (PubMed ID: 15333490)
1. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
D'Agostino RB; Hamman RF; Karter AJ; Mykkanen L; Wagenknecht LE; Haffner SM;
Diabetes Care; 2004 Sep; 27(9):2234-40. PubMed ID: 15333490
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Festa A; D'Agostino R; Tracy RP; Haffner SM;
Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
[TBL] [Abstract][Full Text] [Related]
3. Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients.
Wasada T; Kuroki H; Arii H; Maruyama A; Aoki K; Katsumori K; Saito S; Hanada H; Omori Y
Diabetes Res Clin Pract; 1994 Oct; 25(3):191-8. PubMed ID: 7851274
[TBL] [Abstract][Full Text] [Related]
4. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
Hanley AJ; D'Agostino R; Wagenknecht LE; Saad MF; Savage PJ; Bergman R; Haffner SM;
Diabetes; 2002 Apr; 51(4):1263-70. PubMed ID: 11916954
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
6. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
[TBL] [Abstract][Full Text] [Related]
7. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
[TBL] [Abstract][Full Text] [Related]
8. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
[TBL] [Abstract][Full Text] [Related]
9. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
10. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
Hanley AJ; Williams K; Stern MP; Haffner SM
Diabetes Care; 2002 Jul; 25(7):1177-84. PubMed ID: 12087016
[TBL] [Abstract][Full Text] [Related]
11. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
Bell RA; Mayer-Davis EJ; Martin MA; D'Agostino RB; Haffner SM
Diabetes Care; 2000 Nov; 23(11):1630-6. PubMed ID: 11092284
[TBL] [Abstract][Full Text] [Related]
12. Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus. From the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study.
Mayer-Davis EJ; Monaco JH; Marshall JA; Rushing J; Juhaeri
Prev Med; 1997; 26(3):277-83. PubMed ID: 9144749
[TBL] [Abstract][Full Text] [Related]
13. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
14. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
16. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.
Hanley AJ; Festa A; D'Agostino RB; Wagenknecht LE; Savage PJ; Tracy RP; Saad MF; Haffner SM
Diabetes; 2004 Jul; 53(7):1773-81. PubMed ID: 15220201
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
[TBL] [Abstract][Full Text] [Related]
20. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
